NewsRecent KeyPlants News
We welcome David Lindholm as Head of Sales & Marketing at KeyPlants.
David brings over 19 years of pharmaceutical industry experience. Most recently as European Director of Business Development at Patheon, part of Thermo Fisher. Before joining Patheon in 2014 he worked for Recipharm holding leading roles within Business Management and Project Management.
Throughout his career serving global big pharma companies as well as fast moving biotechs he has gained significant knowledge in all aspect of drug development and manufacturing covering small molecule API’s, Biologics, Fill Finish and OSD.
With his strong background from the global pharmaceutical industry, business development and sales leadership he will be adding significant value to KeyPlants’ organization and to our customers.
The recruitment of David is aligned with KeyPlants’ strategy to further strengthen customer relationships and to become partner of choice for capital investment projects and modular facility solutions.
On February 14th KeyPlants will move to a new office at Lilla Bantorget 15, 111 23 Stockholm.
The large interest for KeyPlants’ services during 2018 has generated several orders for both modular and conventional Pharma and Biotech projects. To ensure continued high quality project deliveries we have expanded our team considerably with several high qualified co-workers. We are therefore now moving to new office space at Lilla Bantorget 15.
We are looking for qualified process- and automation engineers, project managers, with experience from pharma and biotech (or other relevant process industry) to strengthen our team further. Get in contact!
KeyPlants are proud to welcome Ylva Ek as Chief Quality Officer (CQO)
Ylva has a comprehensive experience from working with Quality and GMP from companies in the Pharma and Biotech Industry such as Q-Med and GE Healthcare as well as the Swedish Medical Products Agency (Läkemedelsverket) a part of the European medicines regulatory network, for almost 20 years.
She is active in the International Society of Pharmaceutical Engineering (ISPE) as Chair of ISPE Nordic Affiliate, Chair of Quality and Regulatory sub-group in ISPE Special Interest Group (SIG) – Biotechnology. ISPE EMEA Regulatory Quality Harmonization Committee (RQHC) – Steering Committee.
KeyPlants´ team members are currently involved in two Basic Engineering studies for two European based Big Pharma companies.
Our Subject Matter Experts in process design are delivering optimising and scheduling studies, assisting our Big Pharma customer with de-bottlenecking and optimising bio-processes.